Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Possible Wrong Doings...Optymystic

I understand your point fully, however, keep in mind we're talking about more than 100M shares that were converted and sold by Swartz. In that context, and with the understanding that it took TIME (meaning months/years) to execute those trades, and considering there were periods of lucrative and intense licensing of the MMP, that Swartz's in-house counsel would likely have knowledge of as BoD member to PTSC, if any such knowledge was conveyed to Swartz prior to conveying it to the market publicly, I suspect that is a violation of Reg FD. With that in mind, is, for example, selling AFTER the HPdeal reflecting of selling AFTER the news, or BEFORE the news of the Fujitsu deal one month later?

Share
New Message
Please login to post a reply